Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis

Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy

Stephen R. Durham, Samantha Walker, Eva‐Maria Varga et al. · New England Journal of Medicine · 1999 · 1.4K citations · Full text

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract

A. Hejjaoui, H. Dhivert, F B Michel et al. · Journal of Allergy and Clinical Immunology · 1990 · 338 citations

Autoimmune Disease, Skin Allergy, Clinical Dermatology +4

Generation of Antigen-Specific Suppressor Cells during Allergy Desensitization

Ross E. Rocklin, Albert L. Sheffer, Dirk K. Greineder et al. · New England Journal of Medicine · 1980 · 306 citations

Inflammation, Suppressor-cell Assay, Autoimmune Disease +14

CSM Update: Desensitising vaccines

BMJ · 1986 · 236 citations

Vaccination, Vaccine Safety, Cross-protection +7

Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis

Van Cauwenberge, Juniper · Clinical & Experimental Allergy · 2000 · 168 citations